Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaLiver TransplantationTransplantation ChimeraHematopoietic Stem CellsGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingStem CellsHistocompatibility TestingHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisKidney TransplantationStem Cell TransplantationMice, Inbred C57BLRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationTime FactorsTreatment OutcomeHematologic NeoplasmsImmunosuppressive AgentsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionBone RemodelingHepatic Veno-Occlusive DiseaseBone Marrow NeoplasmsTransplantation ImmunologyLeukemia, MyeloidGraft vs Host ReactionImmunosuppressionLymphocyte DepletionLymphoma, Non-HodgkinLeukocyte TransfusionAcute DiseaseHeart TransplantationColony-Forming Units AssayChimeraT-LymphocytesCell DifferentiationSevere Combined ImmunodeficiencyMyelodysplastic SyndromesHLA AntigensSurvival AnalysisRetrospective StudiesLung TransplantationHematologic DiseasesCyclosporineBone DensityActuarial AnalysisLymphocyte TransfusionCells, CulturedAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyCarmustineOrgan TransplantationPancytopeniaProtein PrecursorsGraft vs Tumor EffectFlow CytometryFollow-Up StudiesGraft vs Leukemia EffectCytarabineLeukocyte CountSpleenSurvival RateGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsMice, Inbred BALB CBone ResorptionMelphalanDisease-Free SurvivalAntigens, CD34EtoposideMultiple MyelomaLymphomaMice, KnockoutCell TransplantationFatal OutcomeCord Blood Stem Cell TransplantationCell SeparationCell Lineage